| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.109.870774 |
| P8608 | Fatcat ID | release_cepzhm6tj5cxtd2wsoo36ydgsq |
| P698 | PubMed publication ID | 19667237 |
| P2093 | author name string | Gábor Szabó | |
| Gábor Veres | |||
| Matthias Karck | |||
| Sivakkanan Loganathan | |||
| Stefan Zöllner | |||
| Tamás Radovits | |||
| Kristóf Hirschberg | |||
| Sevil Korkmaz | |||
| Szabolcs Páli | |||
| Beatrice Seidel | |||
| Philipp Neugebauer | |||
| Eniko Barnucz | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 677-686 | |
| P577 | publication date | 2009-08-10 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury | |
| P478 | volume | 120 |
| Q42514867 | A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy |
| Q41112375 | Acute Catecholamine Exposure Causes Reversible Myocyte Injury Without Cardiac Regeneration. |
| Q34479341 | Acute ethanol exposure increases the susceptibility of the donor hearts to ischemia/reperfusion injury after transplantation in rats |
| Q86109966 | Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats |
| Q53469228 | Administration of zinc complex of acetylsalicylic acid after the onset of myocardial injury protects the heart by upregulation of antioxidant enzymes. |
| Q38040779 | Allosteric regulation of nucleotidyl cyclases: an emerging pharmacological target |
| Q53695762 | Cardioprotection by Intermittent Hypoxia Conditioning: Evidence, Mechanisms and Therapeutic Potential. |
| Q39576954 | Cardioprotective Effect of Ulmus wallichiana Planchon in β-Adrenergic Agonist Induced Cardiac Hypertrophy |
| Q34777781 | Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat. |
| Q34400162 | Cardioprotective role of P38 MAPK during myocardial infarction via parallel activation of α-crystallin B and Nrf2. |
| Q37419185 | Cinaciguat prevents the development of pathologic hypertrophy in a rat model of left ventricular pressure overload |
| Q42075795 | Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. |
| Q60916640 | Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy |
| Q43074266 | Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyperactivity. |
| Q30252419 | Functional Characterization of the GUCY1A3 Coronary Artery Disease Risk Locus |
| Q53612348 | Graft preservation with heparinized blood/saline solution induces severe graft dysfunction. |
| Q27692662 | Heme-dependent and independent soluble guanylate cyclase activators and vasodilation. |
| Q49047822 | Influence of cinaciguat on gastrointestinal motility in apo-sGC mice. |
| Q35053534 | Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols |
| Q46326335 | Modulation of NFKB1/p50 by ROS leads to impaired ATP production during MI compared to cardiac hypertrophy. |
| Q38552442 | Myocardial protection from ischemia-reperfusion injury post coronary revascularization |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q36532454 | Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling |
| Q47133234 | Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation |
| Q36565025 | Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of Ocimum basilicum L. (basil) against isoproterenol induced myocardial infarction in rats |
| Q38367012 | Role of sGC-dependent NO signalling and myocardial infarction risk |
| Q36809512 | Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction. |
| Q35010064 | Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease |
| Q34784680 | Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide |
| Q90633605 | Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation |
| Q38000562 | Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications. |
| Q37071400 | Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction. |
| Q38836199 | Targeting vascular (endothelial) dysfunction. |
| Q36031657 | The alpha1 isoform of soluble guanylate cyclase regulates cardiac contractility but is not required for ischemic preconditioning |
| Q38258238 | The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism |
| Q36234790 | The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus |
| Q28541464 | Total aortic arch replacement: superior ventriculo-arterial coupling with decellularized allografts compared with conventional prostheses |
| Q83179013 | [Ischemic heart disease: 2009 update] |
| Q34244951 | cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action |
Search more.